Concert An Alheimer's  Disease Investigational Trial
Patients and Caregivers
About the study
Entry requirements
Site locations
Clinical studies
Alzheimer's disease
Physcians
About dimebon
About the study
Join the Concert Study
1
Check if there is a study site in your area.
2
Call toll-free
in the United States
in the United Kingdom
in Australia
in New Zealand.
Terms of use
The Concert Study website is a property of Medivation, Inc, and adheres to the same Terms of Use and Privacy Policy as noted below.
The Medivation website is designed to provide general information about Medivation's strategy, history, and product development. It is not intended to provide medical information or investment advice. Access to and use of the Medivation website is subject to all applicable laws and to the terms and conditions set forth below.
Medivation intends to keep the information on this website current, but makes no representation as to its accuracy or completeness. Use of this website is at your own risk, and Medivation accepts no liability for damages occurring from the use of information on this site.
This website contains forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 including statements regarding anticipated future clinical and regulatory milestones. Forward-looking statements involve risks and uncertainties that could cause actual results to differ significantly from those projected. You are cautioned not to place undue reliance on the forward-looking statements. Our filings with the Securities and Exchange Commission include more information about factors that could affect our financial and operating results.
Medivation may revise these terms without prior notice and will post those revisions here.
The Concert Study is a Phase 3 trial sponsored by
Medivation, Inc, and Pfizer Inc.
Aricept® is a registered trademark of Eisai Co, Ltd.
© 2009 Medivation, Inc, and Pfizer Inc. All rights reserved.